Skip to content

The Clinical Efficacy and Mechanisms of Acupuncture Therapy in the Treatment of Severe Depressive Disorders

The Clinical Efficacy and Mechanisms of Acupuncture Therapy in the Treatment of Severe Depressive Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001673
Enrollment
Unknown
Registered
2025-09-04
Start date
2025-06-06
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

the control group:antidepressants
the acupuncture group:acupuncture combined with antidepressants

Sponsors

Shandong Daizhuang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: a. Meets the diagnostic criteria for depressive disorders as outlined in the International Classification of Diseases (ICD-10) including first episode depression and recurrent depressive disorder with a clear diagnosis made using the MINI-International Neuropsychiatric Interview (M.I.N.I.); b. Aged 18 years or older; c. No gender restrictions; d. Have a certain level of education to understand the relevant scale content; e. A Hamilton Depression Rating Scale (HAMD) score of =20 and MADRS score of =28 before randomization; f. The patient or their guardian agrees to participate in this study.

Exclusion criteria

Exclusion criteria: a. Those who meet the diagnostic criteria for other mental disorders such as schizophrenia schizoaffective disorder bipolar disorder obsessive-compulsive disorder and depression caused by physical illnesses; b. Those who have received electroconvulsive therapy within the past 3 months; c. Female patients who are pregnant or breastfeeding; d. Those with serious physical illnesses or other conditions that affect acupuncture treatment; e. First-degree relatives with bipolar disorder; f. Those with significant suicide risk (MADRS item 10 = 5 points); g. Those with severe communication difficulties that prevent normal communication understanding or following instructions and cooperating with treatment and assessors; h. Situations deemed inappropriate for participation by the researcher.

Design outcomes

Primary

MeasureTime frame
Cortisol;Montreal Cognitive Assessment;Activity of Daily Living Scale;the Hamilton Anxiety Rating Scale;Pittsburgh Sleep Quality Index;Montgomery-Asberg Depression Rating Scale;Symptom Checklist-90(SCL-90);Thyroid Function 5 Items;Adrenocorticotropic hormone;the Hamilton Depression Rating Scale;Cholinesterase;

Countries

China

Contacts

Public ContactWANG ZHONGGANG

Shandong Daizhuang Hospital

wzg969@163.com+86 132 8723 9588

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026